Coronary Atherosclerosis T1-Weighted Characterization (CATCH)

NCT03504956 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Coronary Atherosclerosis

Interventions

DEVICE: Cardiac MRI
DRUG: Contrast
DRUG: Beta blocker

Sponsor

Cedars-Sinai Medical Center